MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Effects of computerized cognitive training, with and without concurrent exercise, on executive functions in Parkinson’s disease

    M. Fernandez-del-Olmo, JA. Sánchez-Molina, H. Fernandez-Lago, L. Morenilla-Burlo, J. Gómez-Varela, N. Fogelson (A Coruña, Spain)

    Objective: To explore the effect cognitive training group vs cognitive training with concurrent physical exercise group on executive functions in Parkinson's Disease. Background: PD patients…
  • 2018 International Congress

    Study on Correlation between Serum Vitamin D Level and Cognition of Parkinson’s Disease

    XY. Xu, J. Qian, XS. Huang, SY. Tian, D. Tong (Dalian, China)

    Objective: This article made an elaboration of the correlation between serum vitamin D and cognitive function of PD. Background: Recent years, studies have suggested that…
  • 2018 International Congress

    MicroRNA expression misregulation in iPSC-derived dopaminergic neurons from sporadic and LRRK2-associated Parkinson disease patients

    R. Fernández-Santiago, T. Botta-Orfila, X. Morató, C. Calatayud, R. Raquel, MJ. Martí, C. Gaig, A. Raya, A. Consiglio, E. Tolosa, M. Ezquerra (Barcelona, Spain)

    Objective: To investigate whether miRNA expression alterations occur in iPSC-derived DAn from sporadic PD (sPD) as well as monogenic LRRK2-associated PD patients. Background: MicroRNA (miRNA)…
  • 2018 International Congress

    Resting state networks abnormalities among healthy LRRK2 mutation carriers

    A. Thaler, Y. Jacob, T. Gurevich, R. Helmich, B. Bloem, A. Orr-Urtreger, N. Giladi, L. Yahimovich, A. Mirelman, T. Hendler (Tel-Aviv, Israel)

    Objective: To assess the integrity of resting state networks in non-manifesting carriers of the G2019S mutation in the LRRK2 gene. Background: Non-manifesting first degree relatives…
  • 2018 International Congress

    Lack of TMEM230 mutations in patients with familial and sporadic Parkinson’s disease in a Taiwanese population

    T. Fan, C. Lin, H. Lin, M. Chen, R. Wu (Taoyuan, Taiwan)

    Objective: To confirm the role of mutations in transmembrane protein 230 (TMEM230) in a large number of PD patients and controls in a Taiwanese population.…
  • 2018 International Congress

    MicroRNAs as Biomarkers for Parkinson’s Disease

    S. Bissonnette, C. Thomas, A. Labadorf, R. James, M. Saint-Hilaire, R. Myers (Boston, MA, USA)

    Objective: To identify potential biomarkers for Parkinson’s disease by evaluating miRNA in cerebrospinal fluid samples collected from PD and healthy control subjects. Background: The diagnosis…
  • 2018 International Congress

    Therapeutic Drug Monitoring and Pharmacogenetic Tests as Tools in Pharmacovigilance of Anti Parkinson’s Therapy

    N. Verma (Baddi, India)

    Objective: Parkinson's disease (PD) is the second most prevalent neurodegenerative disease worldwide, affecting more than 7 million people worldwide. However, treatment outcome in many patients…
  • 2018 International Congress

    EEG microstates changes in response to increase in dopaminergic stimulation in treated typical Parkinson’s disease patients without clinical fluctuations

    V. Cortés, I. Serrano, N. Mendes, M. Del Castillo, A. Arroyo, J. Andreo, M. Del Valle, J. Herreros, JP. Romero, (Madrid, Spain)

    Objective: Neurotropic drugs may modulate Electroencephalography (EEG) microstates (MS), but there are no works showing EEG MS default-mode network changes in response to dopaminergic stimulation…
  • 2018 International Congress

    Parkinson’s disease motor symptoms are linked to red nucleus volume and cerebellar metabolism

    A. Bonnet, R. Sanford, A. Riou, S. Drapier, F. Le Jeune, M. Vérin, D.L. Collins (Rennes, France)

    Objective: To investigate the involvement of the red nucleus (RN) and cerebellum in the motor symptoms of Parkinson's disease (PD). Background: Numerous studies have shown…
  • 2018 International Congress

    Cognitive networks in Parkinson’s Disease Mild Cognitive Impairment: Salience Network disruption without gray matter loss

    I. Aracil, F. Sampedro, J. Marin, J. Perez, H. Bejr-Kasem, S. Martinez-Horta, A. Horta, M. Boti, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: To identify neural correlates of mild cognitive impairment in Parkinson’s disease (PD-MCI) according to Level-I Movement Disorders Task Force Criteria (MDS-TF) (1), using a…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
    • Effect of marijuana on Essential Tremor: A case report
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley